Tags

Type your tag names separated by a space and hit enter

Controlling the cost of branded drugs.
Bus Health. 1993 Nov; 11(13):44-6, 48.BH

Abstract

Formularies are no longer used merely to cut costs. The new emphasis is on providing appropriate pharmaceuticals at the most cost-effective price.

Authors

Mandelker J
No affiliation info available

MeSH

Cost ControlDrug CostsFormularies as TopicHealth Benefit Plans, EmployeeInsurance, Pharmaceutical ServicesManaged Care ProgramsPharmacy and Therapeutics CommitteeUnited States

Pub Type(s)

Journal Article

Language

eng

PubMed ID

10130506

Citation

Mandelker, J. "Controlling the Cost of Branded Drugs." Business and Health, vol. 11, no. 13, 1993, pp. 44-6, 48.
Mandelker J. Controlling the cost of branded drugs. Bus Health. 1993;11(13):44-6, 48.
Mandelker, J. (1993). Controlling the cost of branded drugs. Business and Health, 11(13), 44-6, 48.
Mandelker J. Controlling the Cost of Branded Drugs. Bus Health. 1993;11(13):44-6, 48. PubMed PMID: 10130506.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Controlling the cost of branded drugs. A1 - Mandelker,J, PY - 1993/10/5/pubmed PY - 1993/10/5/medline PY - 1993/10/5/entrez SP - 44-6, 48 JF - Business and health JO - Bus Health VL - 11 IS - 13 N2 - Formularies are no longer used merely to cut costs. The new emphasis is on providing appropriate pharmaceuticals at the most cost-effective price. SN - 0739-9413 UR - https://www.unboundmedicine.com/medline/citation/10130506/Controlling_the_cost_of_branded_drugs_ DB - PRIME DP - Unbound Medicine ER -